The University of California San Diego has been ranked the seventh best public university across the globe by Times Higher Education World University Rankings. In its 2016–17 report, the London-based publication ranked UC San Diego 22nd in the United States and 41st internationally.
A three-part series published in The Lancet and released in conjunction with the United Nations quantifies health gains achieved if cities were designed so that shops, facilities, work and public transportation were within walking distance of most residents. In part three of the series published Sept. 23, 2016, researchers tackle how to implement timely research into city design, planning and policy to improve the health of a city’s residents.
Prof. Sahoo – whose journey into the world of cancer genomics was borne from his background in computer science – has been selected as a participating member of the Cancer Genomes and Networks program at UC San Diego Moores Cancer Center.
The Howard Hughes Medical Institute (HHMI), the Simons Foundation, and the Bill & Melinda Gates Foundation today named University of California San Diego Molecular Biology Professor Gürol Süel an HHMI-Simons Faculty Scholar. Süel will receive a total of $1.5 million over five years in support of his studies on how bacterial cells communicate with each other via electrical signals, similar to the way neurons transmit messages in the brain.
The University of California San Diego will host over 1,000 students at SD Hacks 2016 for 36 hours of technological collaboration. This will be the second time SD Hacks will take place at UC San Diego. The student-led hackathon is one of the largest in California, along with those of UC Berkeley and UCLA. After a successful inaugural hackathon in 2015, thousands of students from all over the world have applied to attend this year’s event.
University of California researchers to hold meeting in San Diego to discuss hematologic malignancies as part of the University of California Hematologic Malignancies Consortium, a first-of-its-kind research group that brings together the five UC health campuses conducting clinical studies for cancer patients. The consortium currently has four additional clinical trials planned for 2017.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
